| Date Filed | Type | Description |
| 06/15/2023 |
4
| Ho Tony W (Director) has filed a Form 4 on iTeos Therapeutics, Inc.|
Txns:
| Granted 22,383 options to buy
@ $14.77, valued at
$330.6k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2021 |
4
| Ho Tony W (Executive VP, Head of R&D) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 13,800 options to buy
@ $97, valued at
$1.3M
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Ho Tony W (Executive VP, Head of R&D) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 1,700 shares
@ $148.11, valued at
$251.8k
Sold 900 shares
@ $149.18, valued at
$134.3k
Sold 1,600 shares
@ $150.16, valued at
$240.3k
Sold 1,100 shares
@ $151.58, valued at
$166.7k
Sold 500 shares
@ $152.41, valued at
$76.2k
Sold 1,400 shares
@ $147.05, valued at
$205.9k
Sold 8,400 shares
@ $148.38, valued at
$1.2M
Sold 5,000 shares
@ $149.73, valued at
$748.7k
Sold 2,951 shares
@ $150.61, valued at
$444.5k
Exercised 23,551 options to buy
@ $16.9, valued at
$398k
|
|
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Ho Tony W (Executive VP, Head of R&D) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 229 shares
@ $70.14, valued at
$16.1k
Sold 6,929 shares
@ $75.2, valued at
$521.1k
|
|
| 05/27/2020 |
4
| Ho Tony W (Executive VP, Head of R&D) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Sold 600 shares
@ $70.05, valued at
$42k
Sold 6,100 shares
@ $70.14, valued at
$427.9k
|
|
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| Ho Tony W (Executive VP, Head of R&D) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 40,000 restricted stock units
@ $0 |
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2019 |
4
| Ho Tony W (See Remarks) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 10,000 restricted stock units
@ $40.87, valued at
$408.7k
Granted 75,000 options to buy
@ $40.87, valued at
$3.1M
|
|
| 08/03/2018 |
4
| Ho Tony W (See Remarks) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Paid exercise price by delivering 14,631 shares
@ $48.43, valued at
$708.6k
Exercised 37,500 restricted stock units
@ $0 |
|
| 06/15/2018 |
4
| Ho Tony W (See Remarks) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 43,000 options to buy
@ $59.31, valued at
$2.6M
|
|
| 03/09/2018 |
4
| Ho Tony W (See Remarks) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 53,000 options to buy
@ $51.49, valued at
$2.7M
|
|
| 08/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |